SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is facing intense scrutiny and high volatility after a clinical hold was placed on its gene therapies, RGX-111 and RGX-121, due to a patient developing a brain tumor, leading to widespread community speculation about an impending Complete Response Letter for RGX-121's imminent PDUFA decision.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology Group is trending due to strong preliminary financial results and significantly raised growth outlook, driven by robust demand for its AI data center connectivity solutions from major hyperscalers. The community is actively discussing its valuation and the ongoing relevance of its copper-based technology amidst recent market volatility.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is rallying on community excitement around imminent EU approval for its cancer therapeutic, Anktiva, and intensified discussions of an 'Immunotherapy 2.0' partnership with Saudi Arabia for broad cancer indications. Investors are anticipating a significant short squeeze, validating the company's undervalued platform against recent industry acquisitions and its mission to deliver 'unstoppable' cancer treatments.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON Semiconductor is trending as recent weak guidance for the coming quarter has driven a sell-off and ignited community debate over decelerating automotive and industrial demand. While bears foresee further drops, bulls are underscoring the company's strategic pivot to AI data centers with a significant Nvidia partnership and a large share repurchase program.

Upwork, Inc. is an online marketplace which engages in the provision of businesses to find, hire, and pay freelancers for short-term and longer-term projects. Its marketplace offerings include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The company was founded by Odysseas Tsatalos and Efstratios Karamanlakis in December 2013 and is headquartered in Palo Alto, CA.

Upwork Inc

Upwork is trending following its strong earnings beat, raised guidance, and a new share repurchase program, which are driving renewed bullish sentiment and analyst upgrades. Community discussion centers on its perceived undervaluation and potential for a short squeeze, as the company emphasizes strategic AI innovations within the evolving gig economy.

Amentum Holdings, Inc. engages in mission-critical, technology-driven services in government and commercial markets. It operates through the Digital Solutions and Global Engineering Solutions segments. The Digital Solutions segment provides advanced digital and data-driven solutions including intelligence analytics, space system development, cybersecurity, and next generation IT. The Global Engineering Solutions segment manages large-scale environmental remediation, nuclear power solutions, platform engineering, sustainment and supply chain management. The company was founded on November 26, 2019 and is headquartered in Chantilly, VA.

Amentum Holdings Inc.

Amentum Holdings is trending following its earnings report, sparking community discussion over a notable stock decline despite positive EPS growth and reaffirmed guidance, with many attributing the dip to revenue shifts while maintaining strong long-term confidence in its extensive backlog of critical government, defense, and nuclear contracts.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is seeing intense discussion after halting its compounded GLP-1 weight loss pill amid a patent infringement lawsuit from Novo Nordisk and increased FDA scrutiny, creating a sharp divide among investors debating a potential short squeeze against fundamental concerns over regulatory and legal risks.

Amkor Technology, Inc. engages in the provision of outsourced semiconductor packaging and test services. Its services include design, package characterization, test, and wafer bumping services. The company was founded in 1968 and is headquartered in Tempe, AZ.

AMKOR Technology Inc.

AMKOR Technology is trending after exceeding recent earnings and revenue expectations, driven by strong demand for advanced packaging in AI solutions. While current performance is strong, community discussions highlight concerns over future gross margin guidance and substantial capital expenditures, even as the company expands its role in US semiconductor manufacturing.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl Holdings is trending sharply lower following the abrupt departures of its CFO and General Counsel amid an accounting review and delayed financial filings, sparking intense community discussion about whether the significant sell-off is an extreme overreaction or indicative of severe internal control issues.

Astera Labs, Inc. is a global semiconductor company, which engages in the provision of hardware and software solutions for AI and cloud infrastructure applications to solve data, memory, and networking bottlenecks. It operates through the following geographical segments: Taiwan, China, United States, and Other. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs is a top trending stock, buoyed by recent analyst upgrades and its pivotal role in the rapidly expanding AI data center infrastructure. The community is highly focused on its essential high-speed connectivity solutions, strategic optical technology acquisitions, and potential for significant growth driven by hyperscaler spending.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Twenty One Capital (XXI) shares rose more than 2% in Tuesday's pre-market trading despite the company filing to register up to 35.07 million Class A shares for resale.</li><li>The Form S-1 with the SEC covers shares linked to $486.5 million of convertible notes due in 2030.</li><li>Other crypto-linked stocks, including Strategy, have previously seen pressure following share sales and insider transactions, as investors have viewed them as a cautionary signal.</li></ul>Twenty One Capital (XXI) shares rose in pre-market trading on Tuesday as investors appeared to shrug off dilution concerns following a filing that allows holders of convertible notes to resell more than 35 million Class A shares.In the pre-market session,&nbsp;<a href="https://stocktwits.com/symbol/XXI">Twenty One Capital (XXI)&nbsp;</a>was trading at $10.13, up over 2% after it closed 6.45% higher on Monday at $9.90. This comes after Twenty One Capital filed a Form S-1 to register up to 35.07 million shares of Class A common stock.According to the&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.sec.gov/Archives/edgar/data/2070457/000121390026001285/ea0270549-s1_twenty.htm">filing</a>, the shares are linked to $486.5 million of convertible notes issued earlier by Twenty One Capital. These notes carry a 1.00% interest rate, will mature in 2030, and can be converted into Class A shares. The filing also states that Twenty One will not receive any money from those share sales. It also notes that the company’s Class A common stock does not carry voting rights. Class A common stock refers to the basic ownership unit of a public company. Stockholders typically benefit if the company grows and the share price rises.On Stocktwits, retail sentiment around Twenty One Capital remained in ‘bearish’ territory, with chatter at ‘high’ levels.&nbsp;<h2 class="st-heading-2">Previous Insider Selling</h2>While Twenty One Capital has not disclosed any recent insider selling, similar filings and insider transactions in other crypto-linked stocks have previously unsettled investors.Insiders often have better visibility into a company’s fundamentals, near-term risks, and valuation ceilings, which is why insider selling can be interpreted by market watchers as a cautionary tale.Previously, insider trades caught attention when Strategy (MSTR) CFO Andrew Kang and EVP Wei-Ming Shao&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.sec.gov/Archives/edgar/data/1825170/000095017025105105/xslF345X05/ownership.xml">sold thousands</a> of shares. Soon after, Strategy ended up in a Class-Action lawsuit. According to&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://dockets.justia.com/docket/virginia/vaedce/1:2025cv00861/574369">the filing</a>, the plaintiff alleged that Strategy misrepresented fundamental aspects of its Bitcoin investment strategy, violating federal securities laws.&nbsp;Critics of debt-funded crypto strategies have also flagged balance-sheet stress across the sector. Gold bull and Global Strategist Peter Schiff&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/PeterSchiff/status/1995488341844959356">pointed</a> out that Michael Saylor, Strategy’s executive chairman, was forced to sell stock not to buy Bitcoin (BTC), but to buy “U.S. dollars merely to fund MSTR's interest and dividend obligations.”&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/cryptocurrency/why-coinbase-ceo-brian-armstrong-cannot-buy-coin-on-his-own-platform-app/cmxwVXNR4Tc">Why Coinbase CEO Brian Armstrong Cannot Buy COIN On His Own Platform App</a> For updates and corrections, email newsroom[at]stocktwits[dot]com.

XXI Stock Rises Pre-Market Even As Company Clears Path For Share Resale

Strategy CFO Andrew Kang and EVP Wei-Ming Shao sold thousands of shares in May 2025, and were soon hit with a Class Action lawsuit. 

Equity

Strategy CFO Andrew Kang and EVP Wei-Ming Shao sold thousands of shares in May 2025, and were soon hit with a Class Action lawsuit. 


Twenty One Capital is Now Oversold (XXI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...

Market Doesn't Fully Appreciate Us, Twenty One Capital CEO Mallers Says

Jack Mallers, CEO of Twenty One Capital, joins 'Bloomberg Crypto' to discuss the company's merger with special-purpose acquisition Cantor Equity Partners to become a public crypto company. Twenty One...

The New York Stock Exchange Leads with Seven of the 10 Largest IPOs in 2025, Paves Way for Digital Currency Public Market Debuts

The New York Stock Exchange, part of Intercontinental Exchange, Inc. (NYSE: ICE), a leading global provider of technology and data, today announced it listed seven of the 10 largest IPOs of the year...

NYSE Content Advisory: Market Update + Target Opens Newly Transformed 'Target SoHo' in New York

NYSE Content Advisory: Market Update + Target Opens Newly Transformed 'Target SoHo' in New York NYSE Content Advisory: Market Update + Target Opens Newly Transformed 'Target SoHo' in New York PR...

Twenty One Capital, Inc. is focused on Bitcoin-related business. It offers shareholders a differentiated opportunity to gain exposure to Bitcoin through the equity markets. The company was founded on March 7, 2025 and is headquartered in Austin, TX.

Twenty One Capital Inc. - Ordinary Shares- Class A

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

Current Price	$6.43
Prev Close	$6.51
Open	$6.38
Dividend Yield	0.00%
50-Day Moving Average	$9.24
Beta	0.00
Avg. Volume	1.24M
PE Ratio	19.16

52-Week High	$12.51
52-Week Low	$5.88
Market Capitalization	$2.06B
EPS (Annual)	$0.1201
Price to Book	0.79
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

XXI
Twenty One Capital Inc

Feed

News

Sentiment

Fundamentals

Info

Latest XXI News

XXITwenty One Capital Inc